Early Development of Calcific Aortic Valve Disease and Left Ventricular Hypertrophy in a Mouse Model of Combined Dyslipidemia and Type 2 Diabetes Mellitus
Khaï Le Quang(Institut universitaire de cardiologie et de pneumologie de Québec), André Marette(Université Laval), Dominique Fournier(Institut universitaire de cardiologie et de pneumologie de Québec), Yves Deshaies(Unknown), Xiang Ping Fang(University of Toronto), Diala El Husseini(Université Laval), Rihab Bouchareb(Temple University), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Gary Sweeney(York University), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Marc-André Laplante(University of Toronto), Rita Kohen Avramoglu(University of Toronto), Dominic Lachance(University of Toronto), Philippe Pîbarot(Emory University)
Cited by 52
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
|The Lancet|2016|1k
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832
Staging classification of aortic stenosis based on the extent of cardiac damage
|European Heart Journal|2017|725